CD8A and malignant colon neoplasm: One other study analyzed the densities of intra-tumoral CD3+ and CD8+ in TMA from 1804 colon cancers from QUASAR2 and VICTOR trials and reported that CD8+ TILs were a better predictor than the CD3+ ones [63].